1 EXHIBIT A
To: Wayland Li
City of Fremont Planning Division
39550 Liberty Street
Fremont, CA 94538
From: Andrew Metzger
Circlepoint
42 South First Street, Suite D
San Jose, CA 95112
Subject: I-880 Innovation Bridge and Trail Project Response to Comments Memorandum Date: September 23, 2022
Dear Mr. Li,
The intent of this memorandum is to provide responses to comments received on the I- 880 Innovation Bridge and Trail Project Initial Study/ Mitigated Negative Declaration (IS/MND), which was circulated for public review from August 11, 2022, to September 12, 2022. One comment letter was received. All responses are provided below by commenter and an assigned commenter number. As required pursuant to California Environmental Quality Act (CEQA) Statue and Guidelines, Section 15204, responses to comments that question the adequacy of the environmental analysis in the IS/MND are required. Based on the comment received, the City added new Conditions of Approval incorporating the Department of Toxic Substances Control’s suggestions, but no changes to the IS/MND were required.
As demonstrated by the following discussion, public comments on the draft IS/MND did not identify new environmental impacts or a substantial increase in the severity of an identified impact.
2 EXHIBIT A
3 EXHIBIT A
4 EXHIBIT A
5 EXHIBIT A
Response to Comment Letter 1, Gavin McCreary, Department of Toxic Substances Control
Response to Comment 1: The City of Fremont (the City) has reviewed the recommendations provided by the Department of Toxic Substances Control and has decided that while they are not required to reduce impacts to a less-than-significant level, all of the recommendations are sensible Best Management Practices (BMPs), and have therefore been included as Conditions of Approval. Because these new Conditions of Approval are not required by CEQA and are not necessary to mitigate an avoidable significant effect, recirculation of the Mitigated Negative Declaration is not required (CEQA Guidelines Section 15073.5 (c)(3)). The introductory language of the MND has been revised to include the new Conditions of Approval.
6 EXHIBIT A
This page intentionally left blank.